FMC Dialysis Services North Ramsey is a medicare approved dialysis facility center in Fayetteville, North Carolina and it has 40 dialysis stations. It is located in Cumberland county at 130 Longview Drive, Fayetteville, NC, 28311. You can reach out to the office of FMC Dialysis Services North Ramsey at (910) 482-3491. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Dialysis Services North Ramsey has the following ownership type - Profit. It was first certified by medicare in November, 1998. The medicare id for this facility is 342593 and it accepts patients under medicare ESRD program.
| Name | FMC Dialysis Services North Ramsey |
|---|---|
| Location | 130 Longview Drive, Fayetteville, North Carolina |
| No. of Dialysis Stations | 40 |
| Medicare ID | 342593 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 130 Longview Drive, Fayetteville, North Carolina, 28311 | |
| (910) 482-3491 | |
| Not Available |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
| NPI Number | 1336251156 |
| Organization Name | Fmc Dialysis Services North Ramsey |
| Doing Business As | Bio-medical Applications Of North Carolina, Inc. |
| Address | 130 Longview Dr Fayetteville, North Carolina, 28311 |
| Phone Number | (910) 482-3491 |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 54% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 20% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 26% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 46% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 24% | 14% |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 50% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 22% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 28% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 43% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 32% | 12% |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 71% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 29% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 39% | 12% |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 95 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 165 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1457 |
| Percentage of adult patients getting regular hemodialysis at the center | 92 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Dialysis Services North Ramsey with elevated calcium levels.
| Patients with hypercalcemia | 167 |
| Hypercalcemia patient months | 1477 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 174 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 28 |
| Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 161 |
| Patient months included in arterial venous fistula and catheter summaries | 1148 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 56 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.
Innovative Biosensors, Inc. (IBI) has announced that it has launched the BioFlash Biological Aerosol Collection, Detection and Identification System.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas.
Addressing patients' health-related social needs, like housing and food security, is integral to patient care.
› Verified 1 days ago